 "Kiran Mazumdar Shaw, Biocon CMD")
In view of the COVID-19 pandemic, the government has given clearance for the manufacturing of PCR (polymerase chain reaction)-based kits in India to detect the virus. There are other methods, such as antibody-based tests — which are faster and suitable for large-scale screenings. In an interview, Biocon CMD Kiran Mazumdar-Shaw tells Samreen Ahmad her company’s research arm Syngene is working towards developing such kits. Edited excerpts:
The government has allowed private labs for testing of coronavirus. Is the price cap of Rs 4,500 reasonable?
It is very reasonable because this price cap has been derived from the cost of imported kits.
What other
